Gautam Mankaney
Overview
Explore the profile of Gautam Mankaney including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
197
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
El Halabi J, Burke C, Gault C, Mankaney G
Am J Gastroenterol
. 2023 Jun;
118(10):1733.
PMID: 37335175
No abstract available.
2.
Sleiman J, Farha N, Beard J, Bena J, Morrison S, Milicia S, et al.
Gastrointest Endosc
. 2023 Apr;
98(3):412-419.e8.
PMID: 37031913
Background And Aims: Lynch syndrome (LS) is the most common hereditary cause of colorectal cancer (CRC) and endometrial cancer (EC). Although colonoscopy reduces CRC in LS, the protection is variable....
3.
Samadder N, Foster N, McMurray R, Burke C, Stoffel E, Kanth P, et al.
Gut
. 2022 May;
72(2):256-263.
PMID: 35636921
Importance: Patients with familial adenomatous polyposis (FAP) are at markedly increased risk for duodenal adenomas and cancer. Combination sulindac and erlotinib was previously shown to reduce duodenal polyp burden but...
4.
Shah R, Mehta N, Burke C, Mankaney G, Stevens T, Augustin T, et al.
DEN Open
. 2022 Mar;
2(1):e85.
PMID: 35310730
Objectives: Familial adenomatous polyposis (FAP) patients with Spigelman stage IV polyposis should be considered for prophylactic duodenectomy. Post-surgical pancreaticobiliary complications occur and may require management via endoscopic retrograde cholangiopancreatography (ERCP)....
5.
Venu N, Gault C, Kozarek R, Hwang D, Mankaney G
Am J Gastroenterol
. 2022 Feb;
117(6):837.
PMID: 35175954
No abstract available.
6.
Faisal M, Burke C, Liska D, Lightner A, Leach B, OMalley M, et al.
World J Clin Oncol
. 2022 Feb;
13(1):49-61.
PMID: 35116232
Background: Individuals with Lynch syndrome (LS) and hereditary non-polyposis colorectal cancer (HNPCC) are at increased risk of both colorectal cancer and other cancers. The interplay between immunosuppression, a comorbid inflammatory...
7.
Chouhan H, Abbass M, Hrabe J, Ferrandon S, DeVecchio J, Mankaney G, et al.
Dis Colon Rectum
. 2021 Dec;
65(1):40-45.
PMID: 34882627
Background: Approximately 5% to 10% of patients with Lynch syndrome develop urothelial carcinoma. Current screening recommendations vary and are based on expert opinion. Practices need to be evaluated for clinical...
8.
Mankaney G, Cruise M, Burke C
Gastrointest Endosc
. 2021 Oct;
94(6):1043-1045.
PMID: 34598775
No abstract available.
9.
Farha N, Hrabe J, Sleiman J, Beard J, Lyu R, Bhatt A, et al.
Gastrointest Endosc
. 2021 Jul;
95(1):105-114.
PMID: 34252420
Background And Aims: Lynch syndrome (LS) predisposes patients to multiple cancers including of the gastric and small bowel. Data supporting EGD surveillance in LS are limited. Our aim is to...
10.
Khare A, Burke C, Heald B, OMalley M, LaGuardia L, Milicia S, et al.
J Clin Gastroenterol
. 2021 Jul;
56(3):e183-e188.
PMID: 34231499
Goals And Background: Phosphatase and tensin homolog hamartoma tumor syndrome (PHTS) is an inherited disorder that increases the risk for cancer in multiple organ systems, including breast, endometrial, thyroid, and...